In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma-Reference-Cited by-同舟云学术

In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma

Published:2006-05 Issue:5 Volume:67 Page:1093-1098
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Tian Jun-Qiang,Wang Zhi-Ping,Rodriguez Ronald,Fu Jun-Sheng,Lu Jian-Zhong,Ma Bao-Liang

Publisher

Elsevier BV

Subject

Urology

Reference20 articles.

1. New treatments for metastatic kidney cancer;Mancuso;Can J Urol,2005

2. Tumor-infiltrating lymphocytes and interleukin-2;Dillman;Cancer Biother Radiopharm,2004

3. Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases;Gardini;J Surg Oncol,2004

4. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family;Pitti;J Biol Chem,1996

5. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo;Walczak;Nat Med,1999

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy;The Journal of Immunology;2024-01-15

2. Tumor-infiltrating lymphocytes: Prognostic considerations and current trials as adoptive cell therapy;NK Cells in Cancer Immunotherapy: Successes and Challenges;2023

3. Synthetic TILs: Engineered Tumor-Infiltrating Lymphocytes With Improved Therapeutic Potential;Frontiers in Oncology;2021-02-16

4. NK and T cells with a cytotoxic/migratory phenotype accumulate in peritumoral tissue of patients with clear cell renal carcinoma;Urologic Oncology: Seminars and Original Investigations;2019-07

5. The challenges of adoptive cell transfer in the treatment of human renal cell carcinoma;Cancer Immunology, Immunotherapy;2019-06-20